Mohammad A. Hossain

IM PGY-2 @RutgersIMRes, Clinician Educator Track | @Rutgers_NJMS and @nyuniversity Alum | Interested in Preventative Cardiology & Public Health| 🏃🏽⛰️📸👨🏽‍🍳

[Mohammad A. Hossain @mohossainmd]

Thrilled to have matched into Cardiology Fellowship at @Rutgers_card! A dream come true. Immensely grateful for the support of my mentors, family, friends, and colleagues at @RutgersIMRes. Excited for the journey ahead! 🩺🫀

[Rutgers NJMS Division of Cardiology @RutgersCardio]

🎉Welcome to our newly matched @Rutgers_card Fellows! 🎉
We’re thrilled to have you join the fellowship!
Thank you to our PD @GerulaChristine and all the faculty for an outstanding interview season!
#Match2026 #FellowMatch #CardioTwitter #cardiologymatch @NJACC #ACCFIT

[JACC Journals @JACCJournals]

#HFpEF appears to develop as a result of changes in the biology of a person’s internal fat tissue, according to the #Adipokine Hypothesis, a new way of understanding how fat may impact the heart.

Get the details: https://t.co/9cWrs7ObGh

#JACC #ESCCongress #WCCardio

[Erfan Tasdighi @ErfanTasdighi]

Excited to share the first time ever 🥁

"Sex-Specific CAC Percentiles Across South Asian Adults in U.S."

65% of men and 30% of women have CAC >0 by 55

~75th percentile for 55yo SA men or 65yo SA women is absolute CAC score of 100

link: https://t.co/9lhrGqQTcK
@JACCJournals

[Mohammad A. Hossain @mohossainmd]

Lp(a) is substantially more atherogenic than LDL. Worldwide, 1.4 billion people are affected by elevated Ip(a). A single 400 mg dose of lepodisiran led to a time-averaged reduction of Ip(a) by >93% from 60-180 days.@FITsOnTheGo @ACCinTouch @CleClinicHVTI
https://t.co/i7OEtTTLbE

[Mohammad A. Hossain @mohossainmd]

Rutgers NJMS at #ACC25. Couldn’t ask for a more wonderful group of co-residents 🫶.

@Rutgers_NJMS
@ACCinTouch

[Saad Ur Rahman @SaadUrRahman55]

Takeaways from #ACC2025. Late breaking trials - take home points
@ACCinTouch

1. WARRIOR Trial : Intensive medical therapy did not significantly impact the rate of serious cardiovascular events at five years in women with suspected ischemia with nonobstructive coronary arteries (INOCA).

[Mohammad A. Hossain @mohossainmd]

Grateful for the opportunity to present our work on Trends and Disparities in Cardiovascular Disease Related Maternal Mortality in the US at #ACC25.

@ACCinTouch
@RutgersIMRes

[Mohammad A. Hossain @mohossainmd]

It was my distinct pleasure to interview Dr. Nissen. Promising findings in treatment for elevated lp(a)!

[FITsOnTheGo @FITsOnTheGo]

The ALPACA Phase 2 trial studied Lepodisiran, a small-interfering RNA, with results extending out to 540 days.
Extended durability, promising reductions. We had the absolute pleasure to talk with Dr Nissen from @ClevelandClinic at #ACC25 @mohossainmd @RutgersIMRes

[C. Michael Gibson MD @CMichaelGibson]

Late-breaker at #ACC2025: Dr. Steven Nissen presented the phase 2 ALPACA trial, showing substantial & durable Lp(a) reductions by lepodisiran, an siRNA therapy. Slides here: https://t.co/JaukQ1dqrx

[Adarsh G. Balaji, MD @AdarshGBalaji]

Another amazing day at #ACC! So proud of our interns for presenting their cases with such confidence. Loved making new friends and reconnecting with old ones—especially my study abroad roommate from Sydney back in 2015! 🎉🫀@ACCinTouch @OBHBrookdaleIM @OBH_Cardiology

[Mohammad A. Hossain @mohossainmd]

Excited to present our findings at #ACC25! Join us at Moderated Poster Theater 9 on Saturday, March 29th, @ 9:42 AM. @RutgersIMRes @ACCinTouch

[ACC Media Center @ACCmediacenter]

An #ACC25 study led by @Mohossainmd of @Rutgers_NJMS, found that maternal mortality due to #CVD has more than doubled between 1999-2022—concerning, given the U.S. has the highest maternal mortality rate among developed countries. 👩🏽‍🍼 https://t.co/JPAYYgvkYL

[American College of Cardiology @ACCinTouch]

Learn about the unique role of Lp(a) as a genetic determinant for #ASCVD risk & the importance of testing for Lp(a) levels to better understand your patients’ cardiovascular health w/ ACC's online course. ⬇️

More: https://t.co/OY9j8m0p5g

#LpaAwarenessDay #KnowLpa #ACCEd